CONMED Corporation Announces Quarterly Cash Dividend
February 27 2023 - 4:05PM
Business Wire
CONMED Corporation (NYSE: CNMD) today
announced that its Board of Directors has declared a quarterly cash
dividend of $0.20 per share, payable on April 5, 2023, to all
shareholders of record as of March 15, 2023.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and physicians in a variety
of specialties, including orthopedics, general surgery, gynecology,
thoracic surgery, and gastroenterology. For more information, visit
www.conmed.com.
Forward-Looking Statements
This press release may contain forward-looking statements based
on certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or
trends to differ materially from those expressed in the
forward-looking statements herein or in previous disclosures. For
example, in addition to general industry and economic conditions,
factors that could cause actual results to differ materially from
those in the forward-looking statements may include, but are not
limited to, the risks posed to the Company’s business, financial
condition, and results of operations by the COVID-19 global
pandemic and the various government responses to the pandemic,
including deferral of surgeries, reductions in hospital and
ambulatory surgery center operating volumes, disruption to
potential supply chain reliability; any assumptions underlying any
of the foregoing as well as the risk factors discussed in the
Company's Annual Report on Form 10-K for the full year ended
December 31, 2022, listed under the heading Forward-Looking
Statements in the Company’s most recently filed Form 10-K and other
risks and uncertainties which may be detailed from time to time in
reports filed by CONMED with the SEC. Any and all forward-looking
statements are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995 and relate to the
Company’s performance on a going-forward basis. The Company
believes that all forward-looking statements made by it have a
reasonable basis, but there can be no assurance that management’s
expectations, beliefs or projections as expressed in the
forward-looking statements will actually occur or prove to be
correct.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230227005807/en/
CONMED Corporation Todd Garner Chief Financial Officer
727-214-2975 ToddGarner@conmed.com
CONMED (NYSE:CNMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
CONMED (NYSE:CNMD)
Historical Stock Chart
From Jul 2023 to Jul 2024